These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33598818)

  • 21. Microneedles: An Emerging Vaccine Delivery Tool and a Prospective Solution to the Challenges of SARS-CoV-2 Mass Vaccination.
    Feng YX; Hu H; Wong YY; Yao X; He ML
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
    Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
    Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term stability of influenza vaccine in a dissolving microneedle patch.
    Mistilis MJ; Joyce JC; Esser ES; Skountzou I; Compans RW; Bommarius AS; Prausnitz MR
    Drug Deliv Transl Res; 2017 Apr; 7(2):195-205. PubMed ID: 26926241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection.
    Xu F; Yuan Y; Wang Y; Yin Q
    Biomed Pharmacother; 2023 Feb; 158():114117. PubMed ID: 36528914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
    Bernelin-Cottet C; Urien C; McCaffrey J; Collins D; Donadei A; McDaid D; Jakob V; Barnier-Quer C; Collin N; Bouguyon E; Bordet E; Barc C; Boulesteix O; Leplat JJ; Blanc F; Contreras V; Bertho N; Moore AC; Schwartz-Cornil I
    J Control Release; 2019 Aug; 308():14-28. PubMed ID: 31265882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles vaccination using a microneedle patch.
    Edens C; Collins ML; Ayers J; Rota PA; Prausnitz MR
    Vaccine; 2013 Jul; 31(34):3403-9. PubMed ID: 23044406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
    Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
    Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mini review for lipid-based nanovaccines: from their design to their applications.
    Xekouki K; Lagopati N; Demetzos C; Gazouli M; Pippa N
    J Liposome Res; 2023 Sep; 33(3):214-233. PubMed ID: 36856671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens.
    Kommareddy S; Baudner BC; Oh S; Kwon SY; Singh M; O'Hagan DT
    J Pharm Sci; 2012 Mar; 101(3):1021-7. PubMed ID: 22190403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticles as Adjuvants in Vaccine Delivery.
    Garg A; Dewangan HK
    Crit Rev Ther Drug Carrier Syst; 2020; 37(2):183-204. PubMed ID: 32865905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of influenza vaccine coated onto microneedles.
    Choi HJ; Yoo DG; Bondy BJ; Quan FS; Compans RW; Kang SM; Prausnitz MR
    Biomaterials; 2012 May; 33(14):3756-69. PubMed ID: 22361098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Devices for intradermal vaccination.
    Kis EE; Winter G; Myschik J
    Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin immunization with third-generation hepatitis B surface antigen using microneedles.
    Nguyen TT; Choi JA; Kim JS; Park H; Yang E; Lee WJ; Baek SK; Song M; Park JH
    Vaccine; 2019 Sep; 37(40):5954-5961. PubMed ID: 31466705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal nanovaccines.
    Bernocchi B; Carpentier R; Betbeder D
    Int J Pharm; 2017 Sep; 530(1-2):128-138. PubMed ID: 28698066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
    Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
    PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifaceted therapeutic applications of biomimetic nanovaccines.
    Chheda D; Shete S; Tanisha T; Devrao Bahadure S; Sampathi S; Junnuthula V; Dyawanapelly S
    Drug Discov Today; 2024 Jun; 29(6):103991. PubMed ID: 38663578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microneedles for drug and vaccine delivery.
    Kim YC; Park JH; Prausnitz MR
    Adv Drug Deliv Rev; 2012 Nov; 64(14):1547-68. PubMed ID: 22575858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in microneedles-based drug delivery device in the diagnosis and treatment of cancer.
    Singh V; Kesharwani P
    J Control Release; 2021 Oct; 338():394-409. PubMed ID: 34481019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.